The short answer: Ozempic can be safe and effective for many older adults, but it requires more careful monitoring than it does for younger patients, particularly around muscle mass, nutritional intake, and kidney function
Sirtuin activity declines proportionally with NAD+ levels, reducing stress resistance and promoting cellular senescence
Experimental evidence supports this integrated model
It may involve Medicare negotiating the price for semaglutide with Novo Nordisk, or having insurers pay for it using a subscription model, similar to what was done for hepatitis C treatments when they were first released
Patients without personal or familial thyroid cancer history can use semaglutide safely
A study of 112 patients treated with SRS reported a 1-year distant intracranial failure rate of 54%, with tumor histology and number of BM as significant predictors [11]